Amid volatility in technology stocks and whispers of rotation toward value sectors, State Street Global Advisors maintains that the artificial intelligence (AI) rally is far from over. The Boston-based asset manager argues that despite intermittent pullbacks, the underlying structure of the AI-driven market remains intact — a function of deep capital expenditure cycles, investor psychology,…
In a bold strategic move designed to reposition itself in the booming weight-loss therapeutics market, Pfizer Inc. has secured the acquisition of Metsera, Inc., outbidding its rival Novo Nordisk A/S in a contest that underscores how and why the pharmaceutical giant is shifting its growth playbook. The deal marks more than just an asset purchase—it…
Negotiations between YouTube TV and The Walt Disney Company have entered a critical phase as YouTube publicly stated it is ready to cut a binding deal to restore Disney’s networks — including ABC and ESPN — to its live-TV platform in the United States. The dispute has exposed deeper shifts in carriage-fee leverage, streaming business…
Russia’s wine market is undergoing a profound transformation. Once brimming with French Burgundies, Italian Barolos and South American imports, supermarket shelves now showcase mainly Russian-made vintages. The shift, punctuated by Western sanctions after the invasion of Ukraine in early 2022, is not simply a consumer re-orientation—it embodies changing trade flows, protectionist impulses and a broader…
France has launched formal proceedings to suspend operations of Chinese fast-fashion giant Shein after authorities discovered the online marketplace was selling prohibited items — including childlike sex dolls and banned weapons. The timing was striking: the government’s move came on the same day Shein opened its first physical store in Paris, turning what was meant…
The recent agreement by major drug manufacturers to reduce monthly costs of weight-loss medications is poised to unlock access for millions of Americans who had previously been priced out. Lower out-of-pocket costs, expanded insurance eligibility — particularly for older adults — and increased availability of oral options are reshaping the treatment landscape. But while the…
Eli Lilly’s injectable weight-loss drug Mounjaro has rapidly overtaken established pharmaceuticals in India’s competitive market, emerging as the country’s top-selling drug by value in October 2025. The milestone reflects a seismic shift in healthcare priorities among Indian consumers and doctors, where chronic diseases and body-weight management have become central medical and social concerns. Mounjaro’s rise…
In the global race to dominate artificial intelligence, India has quietly emerged as the world’s largest open laboratory. Free AI tools from Google, OpenAI, and Perplexity are flooding the Indian market — not just as acts of goodwill, but as part of a calculated strategy to capture and harness the digital behaviors of over 700…
Pfizer has lifted its 2025 profit forecast for the second consecutive quarter, signaling renewed financial stability and strategic resilience after a turbulent period marked by waning pandemic-era sales. The upward revision underscores how the U.S. pharmaceutical giant is navigating its post-COVID transition through disciplined cost management, robust performance of key therapies, and targeted product launches…
China’s manufacturing sector sank deeper in October, with the official Purchasing Managers’ Index (PMI) falling to 49.0—its weakest reading in six months and below economists’ expectations. The downturn continues a contractionary streak that now stretches into its seventh consecutive month, highlighting how external shocks, weak domestic demand and structural challenges are converging to test the…
business-gurus.com 